Return to Clinical Trials Search Results

Intermediate-Size Patient Population Expanded Access of NanoPac® for the Treatment of Localized Esophageal Cancer

To provide access to NanoPac to patients with localized esophageal cancer who have failed prior therapy, are not surgical candidates, or are refusing surgery at this time.

Recruitment Status

Current Studies